{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:53:12Z","timestamp":1768006392828,"version":"3.49.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2002,1,1]],"date-time":"2002-01-01T00:00:00Z","timestamp":1009843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,1,1]],"date-time":"2002-01-01T00:00:00Z","timestamp":1009843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2002,1]]},"DOI":"10.1016\/s0002-9343(01)01034-8","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T05:26:55Z","timestamp":1027574815000},"page":"49-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":117,"title":["Current medical therapies for patients with peripheral arterial disease: a critical review"],"prefix":"10.1016","volume":"112","author":[{"given":"Judith G","family":"Regensteiner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William R","family":"Hiatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0002-9343(01)01034-8_BIB1","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1161\/01.CIR.71.3.510","article-title":"The prevalence of peripheral arterial disease in a defined population","volume":"71","author":"Criqui","year":"1985","journal-title":"Circulation"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB2","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1161\/01.CIR.91.5.1472","article-title":"Effect of diagnostic criteria on the prevalence of peripheral arterial disease. The San Luis Valley Diabetes Study","volume":"91","author":"Hiatt","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1532-5415.1985.tb02853.x","article-title":"Update on some epidemiologic features of intermittent claudication","volume":"33","author":"Kannel","year":"1985","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB4","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/00000658-198402000-00016","article-title":"Coronary artery disease in peripheral vascular patients. A classification of 1000 coronary angiograms and results of surgical management","volume":"199","author":"Hertzer","year":"1984","journal-title":"Ann Surg"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB5","first-page":"50","article-title":"Fate of the patient with chronic leg ischaemia. A review article","volume":"30","author":"Dormandy","year":"1989","journal-title":"J Cardiovasc Surg"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB6","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/0002-9149(94)90493-6","article-title":"Prevalence of coexistence of coronary artery disease, peripheral arterial disease, and atherothrombotic brain infarction in men and women \u2265 62 years of age","volume":"74","author":"Aronow","year":"1994","journal-title":"Am J Cardiol"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB7","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1056\/NEJM199202063260605","article-title":"Mortality over a period of 10 years in patients with peripheral arterial disease","volume":"326","author":"Criqui","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB8","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/jama.1993.03510040069031","article-title":"Decreased ankle\/arm blood pressure index and mortality in elderly women","volume":"270","author":"Vogt","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB9","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/ije\/25.6.1172","article-title":"Incidence, natural history, and cardiovascular events in symptomatic, and asymptomatic peripheral arterial disease in the general population","volume":"25","author":"Leng","year":"1996","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB10","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1161\/01.ATV.19.3.538","article-title":"Ankle-arm index as a predictor of cardiovascular disease, and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group","volume":"19","author":"Newman","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB11","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1111\/j.1532-5415.1997.tb03198.x","article-title":"Mortality over four years in SHEP participants with a low ankle-arm index","volume":"45","author":"Newman","year":"1997","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB12","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/000331979504600304","article-title":"Ankle\/arm pressure index in asymptomatic middle-aged males","volume":"46","author":"Kornitzer","year":"1995","journal-title":"Angiology"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB13","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s11606-006-5042-4","article-title":"Atherosclerotic risk factors are less intensively treated in patients with peripheral arterial disease than in patients with coronary artery disease","volume":"12","author":"McDermott","year":"1997","journal-title":"J Gen Intern Med"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB14","unstructured":"Hirsch AT, Criqui MH, Treat-Jacobson D, The PARTNERS Program: a national survey of peripheral arterial disease prevalence, awareness, and ischemic risk. JAMA. (in Press)"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB15","first-page":"163","article-title":"Exercise conditioning in the treatment of patients with peripheral arterial disease","volume":"2","author":"Hiatt","year":"1990","journal-title":"J Vasc Med Biol"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB16","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1161\/01.CIR.90.4.1866","article-title":"Superiority of treadmill walking exercise versus strength training for patients with peripheral arterial disease","volume":"90","author":"Hiatt","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB17","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0741-5214(05)80040-0","article-title":"Exercise training improves functional status in patients with peripheral arterial disease","volume":"23","author":"Regensteiner","year":"1996","journal-title":"J Vasc Surg"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB18","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1161\/01.CIR.94.11.3026","article-title":"Diagnosis and treatment of chronic arterial insufficiency of the lower extremities","volume":"94","author":"Weitz","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB19","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.308.6921.81","article-title":"Collaborative overview of randomised trials of antiplatelet therapy. I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients","volume":"308","year":"1994","journal-title":"BMJ"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB20","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2796.1990.tb00164.x","article-title":"Prevention of myocardial infarction and stroke in patients with intermittent claudication; effects of ticlopidine. Results from STIMS, the Swedish Ticlopidine Multicenter Study","volume":"227","author":"Janzon","year":"1990","journal-title":"J Int Med"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB21","first-page":"523","article-title":"Results of EMATAP","volume":"35","author":"Blanchard","year":"1994","journal-title":"Nouv Rev Fr Hematol"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB22","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB23","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on death from cardiovascular causes","volume":"342","author":"Yusuf","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB24","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB25","first-page":"CD000123","article-title":"Lipid-lowering for lower limb atherosclerosis (Cochrane Review)","volume":"2","author":"Leng","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB26","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.280.7.605","article-title":"Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen\/progestin Replacement Study (HERS) Research Group","volume":"280","author":"Hulley","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB27","first-page":"CD000990","article-title":"Exercise for intermittent claudication","volume":"2","author":"Leng","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB28","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/archinte.159.4.337","article-title":"Treatment of intermittent claudication with physical training, smoking cessation, pentoxifylline, or nafronyl","volume":"159","author":"Girolami","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB29","first-page":"1053","article-title":"Management of intermittent claudication with pentoxifylline","volume":"155","author":"Hood","year":"1996","journal-title":"Can Med Assoc J"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB30","first-page":"198","article-title":"Improvements in quality of life in cilostazol-treated patients with intermittent claudication","volume":"5","author":"Regensteiner","year":"2000","journal-title":"Vasc Med"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB31","first-page":"56802","article-title":"Internal analgesic antipyretic and antirheumatic drug products for over the counter human use","volume":"63","year":"1998","journal-title":"Fed Regist"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB32","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1093\/ajhp\/56.15.1505","article-title":"Review of the Fifth American College of Chest Physicians Consensus Conference on Antithrombotic Therapy","volume":"56","author":"Sachdev","year":"1999","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB33","first-page":"CD001246","article-title":"Thienopyridine derivatives (ticlopidine, clopidogrel) versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients","volume":"2","author":"Hankey","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB34","doi-asserted-by":"crossref","first-page":"541","DOI":"10.7326\/0003-4819-128-7-199804010-00004","article-title":"Thrombotic thrombocytopenic purpura associated with ticlopidine. A review of 60 cases","volume":"128","author":"Bennett","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB35","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJM200006153422402","article-title":"Thrombotic thrombocytopenic purpura associated with clopidogrel","volume":"15;342","author":"Bennett","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB36","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0021-9150(99)00447-5","article-title":"Femoral atherosclerosis in an older British population","volume":"152","author":"Leng","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB37","first-page":"61","article-title":"National Heart and Lung Institute, National Institutes of Health. The Framingham Study","volume":"28","author":"Kannel","year":"1973","journal-title":"Geriatrics"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB38","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1177\/1358863X9700200314","article-title":"The role of tobacco cessation, antiplatelet and lipid-lowering therapies in the treatment of peripheral arterial disease","volume":"2","author":"Hirsch","year":"1997","journal-title":"Vasc Med"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB39","doi-asserted-by":"crossref","first-page":"135","DOI":"10.7326\/0003-4819-113-2-135","article-title":"Conservative management of intermittent claudication. PRIVATE","volume":"113","author":"Radack","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB40","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1532-5415.1985.tb02853.x","article-title":"Update on some epidemiologic features of intermittent claudication","volume":"33","author":"Kannel","year":"1985","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB41","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1001\/jama.1979.03290450033020","article-title":"Diabetes and cardiovascular disease. The Framingham Study","volume":"241","author":"Kannel","year":"1979","journal-title":"JAMA"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB42","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/0002-8703(90)90026-T","article-title":"Diabetes, fibrinogen, and risk of cardiovascular disease","volume":"120","author":"Kannel","year":"1990","journal-title":"Am Heart J"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB43","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.2337\/diacare.18.12.1534","article-title":"Long-term glycemic control relates to mortality in type II diabetes","volume":"18","author":"Andersson","year":"1995","journal-title":"Diabetes Care"},{"issue":"suppl 1","key":"10.1016\/S0002-9343(01)01034-8_BIB44","first-page":"S33","article-title":"Standards of medical care for patients with diabetes mellitus","volume":"24","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB45","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1161\/01.CIR.96.1.44","article-title":"Intermittent claudication. A risk profile from the Framingham Heart Study","volume":"96","author":"Murabito","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB46","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/oxfordjournals.aje.a116709","article-title":"Prevalence and correlates of lower extremity arterial disease in elderly women","volume":"137","author":"Vogt","year":"1993","journal-title":"Am J Epidemiol"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB47","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1177\/000331978703800402","article-title":"Systolic hypertension in patients with arteriosclerosis obliterans of the lower limbs","volume":"38","author":"Safar","year":"1987","journal-title":"Angiology"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB48","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1001\/archinte.1997.00440420033005","article-title":"The sixth report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure","volume":"157","year":"1997","journal-title":"Arch Intern Med."},{"key":"10.1016\/S0002-9343(01)01034-8_BIB49","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease","volume":"344","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB50","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB51","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1056\/NEJM199104253241701","article-title":"Hyperhomocysteinemia: an independent risk factor for vascular disease","volume":"324","author":"Clarke","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB52","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1365-2796.1992.tb00535.x","article-title":"Hyperhomocyst(e)inaemia","volume":"231","author":"Molgaard","year":"1992","journal-title":"J Int Med"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB53","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0741-5214(91)90020-U","article-title":"The association of elevated plasma homocyst(e)ine with progression of symptomatic peripheral arterial disease","volume":"13","author":"Taylor","year":"1991","journal-title":"J Vasc Surg"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB54","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0378-5122(95)01000-9","article-title":"Transdermal estrogen replacement therapy","volume":"24","author":"Lindoff","year":"1996","journal-title":"Maturitas"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB55","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1749-6632.1990.tb30338.x","article-title":"The epidemiology of cardiovascular disease in postmenopausal women","volume":"592","author":"Bush","year":"1990","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB56","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0378-5122(89)90023-6","article-title":"Oestrogen replacement therapy and cardiovascular disease in post-menopausal women. A review","volume":"11","author":"Sitruk-Ware","year":"1989","journal-title":"Maturitas"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB57","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0140-6736(66)92191-X","article-title":"Effect of daily muscular exercise in patients with intermittent claudication","volume":"2","author":"Larsen","year":"1966","journal-title":"Lancet"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB58","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1161\/01.CIR.39.3.353","article-title":"Exercise and intermittent claudication. Blood flow in the calf muscle during walking studied by the xenon-133 clearance method","volume":"39","author":"Alpert","year":"1969","journal-title":"Circulation"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB59","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2340\/1650197784159162","article-title":"The effects of physical training and flunarizine on walking capacity in intermittent claudication","volume":"16","author":"Lepantalo","year":"1984","journal-title":"Scand J Rehab Med"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB60","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1365-2362.1974.tb00365.x","article-title":"Metabolic activity of skeletal muscle in patients with peripheral arterial insufficiency. Effect of physical training","volume":"4","author":"Dahllof","year":"1974","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB61","first-page":"137","article-title":"Home-training of patients with intermittent claudication","volume":"13","author":"Jonason","year":"1981","journal-title":"Scand J Rehab Med"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB62","first-page":"363","article-title":"Isokinetic plantar flexor performance and fatiguability in peripheral arterial insufficiency","volume":"154","author":"Hedberg","year":"1988","journal-title":"Acta Chir Scand"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB63","first-page":"569","article-title":"The effects of an intensive 26-day program of diet and exercise on patients with peripheral vascular disease","volume":"2","author":"Hall","year":"1982","journal-title":"J Cardiac Rehabil"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB64","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3109\/00365517809108414","article-title":"Effects of physical training in intermittent claudication","volume":"38","author":"Sorlie","year":"1978","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB65","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1067\/mva.2000.104422","article-title":"Effects of exercise rehabilitation on cardiovascular risk factors in older patients with peripheral arterial occlusive disease","volume":"31","author":"Izquierdo-Porrera","year":"2000","journal-title":"J Vasc Surg"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB66","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/0002-8703(82)90642-1","article-title":"Pentoxifylline efficacy in the treatment of intermittent claudication","volume":"104","author":"Porter","year":"1982","journal-title":"Am Heart J"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB67","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1161\/01.CIR.80.6.1549","article-title":"Conservative drug treatment in patients with moderately severe chronic occlusive peripheral arterial disease","volume":"80","author":"Lindgarde","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB68","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0049-3848(99)00109-7","article-title":"Effect of cilostazol, a phosphodiesterase III inhibitor, on experimental thrombosis in the porcine carotid artery","volume":"96","author":"Kohda","year":"1999","journal-title":"Thromb Res"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB69","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/0049-3848(90)90079-R","article-title":"Potentiation of anti-platelet aggregating activity of cilostazol with vascular endothelial cells","volume":"57","author":"Igawa","year":"1990","journal-title":"Thromb Res"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB70","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1161\/01.CIR.100.1.21","article-title":"Impact of cilostazol on restenosis after percutaneous coronary balloon angioplasty","volume":"100","author":"Tsuchikane","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB71","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1001\/archinte.159.17.2041","article-title":"A new pharmacological treatment for intermittent claudication","volume":"159","author":"Beebe","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB72","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1161\/01.ATV.18.12.1942","article-title":"Effect of the novel antiplatelet agent cilostazol on plasma lipoproteins in patients with intermittent claudication","volume":"18","author":"Elam","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB73","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0741-5214(98)70357-X","article-title":"Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease","volume":"27","author":"Money","year":"1998","journal-title":"J Vasc Surg"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB74","first-page":"I-12","article-title":"Two doses of cilostazol versus placebo in the treatment of claudication","volume":"95","author":"Strandness","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/S0002-9343(01)01034-8_BIB75","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0002-9343(00)00569-6","article-title":"A comparison of cilostazol and pentoxifylline for treating intermittent claudication","volume":"109","author":"Dawson","year":"2000","journal-title":"Am J Med"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934301010348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934301010348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T08:19:54Z","timestamp":1757578794000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934301010348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1]]},"references-count":75,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,1]]}},"alternative-id":["S0002934301010348"],"URL":"https:\/\/doi.org\/10.1016\/s0002-9343(01)01034-8","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2002,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current medical therapies for patients with peripheral arterial disease: a critical review","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S0002-9343(01)01034-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2001 Excerpta Medica Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}